Vemurafenib-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemia cutis A novel variant of BRAF inhibitor associated panniculitis with histiocytoid infiltrate of immature neutrophils


Por: Richarz, NA, Puig, L, Perez, N, Cuadra-Urteaga, J, Elez, E and Fernandez-Figueras, MT

Publicada: 4 mar 2019 Ahead of Print: 14 nov 2018
Resumen:
Neutrophilic panniculitis is an infrequent but characteristic adverse event under therapy with BRAF inhibitors (BRAFi). Since the approval of vemurafenib for treatment of metastatic melanoma in 2011, only two cases of neutrophilic panniculitis in malignancies other than melanoma have been published. Histiocytoid infiltrates of immature neutrophils resembling histiocytes or myelocytes have been reported in Sweet's syndrome and rarely in other neutrophilic dermatoses. We describe a novel variant of neutrophilic panniculitis with histiocytoid myeloid cells in an early lesion from a patient treated with vemurafenib in combination with an anti-EGFR (epidermal growth factor receptor) agent for metastatic colon carcinoma, three weeks after initiation of therapy. Recognizing this variant of panniculitis associated to BRAFi can avoid misinterpretation of the atypical subcutaneous infiltrate as myeloid leukaemia cutis.

Filiaciones:
:
 Univ Germans Trias i Pujol, Dept Dermatol, Barcelona, Spain

 Univ Autonoma Barcelona, Barcelona, Spain

Puig, L:
 Univ Autonoma Barcelona, Barcelona, Spain

 Hosp Santa Creu & Sant Pau, Dept Dermatol, Barcelona, Spain

Perez, N:
 Univ Internac Catalunya, Hosp Univ Gen Catalunya QuironSalud, Dept Pathol, Barcelona, Spain

Cuadra-Urteaga, J:
 Univ Autonoma Barcelona, Barcelona, Spain

 Hosp Quiron, IOB Inst Oncol, Dept Med Oncol, Barcelona, Spain

Elez, E:
 Univ Autonoma Barcelona, Barcelona, Spain

 Hosp Quiron, IOB Inst Oncol, Dept Med Oncol, Barcelona, Spain

 Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

 Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

Fernandez-Figueras, MT:
 Univ Internac Catalunya, Hosp Univ Gen Catalunya QuironSalud, Dept Pathol, Barcelona, Spain
ISSN: 15384047





CANCER BIOLOGY & THERAPY
Editorial
Landes Bioscience, 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 20 Número: 3
Páginas: 237-239
WOS Id: 000457544200001
ID de PubMed: 30426827
imagen Green Published, Bronze

MÉTRICAS